• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Cigna Group (CI) Could Be 54% Undervalued On Mixed Third Quarter Earnings

    Simply Wall St·11/09/2026 00:20:27
    Listen to the news

    Earnings event reshapes the Cigna Group story

    Cigna Group (CI) just put fresh numbers on the table. Third quarter 2026 results showed higher sales and revenue alongside lower quarterly earnings, setting up a mixed backdrop for anyone tracking the stock’s risk and reward profile.

    The share price reaction has been muted rather than euphoric. At US$293.59, Cigna Group has slipped over the past day and week, yet still shows a 3.95% 1-month share price return and a 5.18% year-to-date share price gain. The 1-year total shareholder return of 13.48% signals that, despite recent earnings-driven caution, momentum over a longer window has been building rather than fading.

    Scan how Cigna Group stacks up against other potential breakout candidates by reviewing our hand-picked 38 high quality undervalued stocks that combine cash flow strength with solid balance sheets.

    Cigna Group just delivered rising sales but softer quarterly earnings, and the share price has cooled after a strong year. Is that enough of a reset to buy now, or does waiting for a cheaper entry point make more sense?

    Most Popular Narrative: 54% Undervalued

    Cigna Group closed at $293.59, while the most followed narrative from Simply Wall St users pegs fair value at $636.28. That gap is large enough that the narrative spends most of its time asking whether the discount is a bargain or a warning label.

    Cigna offers a 55.3% raw discount because the market is not valuing growing earnings in isolation. It is pricing political hostility toward PBMs, restrictions on Express Scripts, uncertainty around automated claims review, declining customer counts, uneven cash conversion, and the possibility that today’s most profitable practices may not remain tomorrow’s permissible ones.

    See why 6 investors see Cigna Group as 54% undervalued.

    Result: Fair Value of $636.28 (UNDERVALUED)

    Still, the Cigna Group story could shift quickly if the Express Scripts monitoring tightens further or if the PxDx litigation outcome undercuts confidence in its automation model.

    Find out about the key risks to this Cigna Group narrative.

    Next Steps

    Mixed signals can feel uncomfortable, which is exactly why it helps to move fast and look at the full picture for Cigna Group yourself. To see how current concerns line up against potential upside, take a closer look at the 4 key rewards and 1 important warning sign.

    Want more ideas beyond Cigna Group?

    If Cigna Group has your attention, do not stop here. Broader context from other opportunities can sharpen your judgement and help you position your next move with intent.

    • Spot potential price dislocations early by scanning a curated 38 high quality undervalued stocks that pair healthy cash generation with disciplined balance sheets.
    • Lock in cash flow potential by reviewing a focused 7 dividend fortresses built around companies offering higher yields with an emphasis on resilience.
    • Protect your downside first by working through a targeted 31 resilient stocks with low risk scores designed to highlight businesses with stronger risk profiles.